Modafinil

CAS Number: 68693-11-8

Molecular Formula: C15H15NO2S

Buy Modafinil 200mg onlinePharmaceutical grade Modafinil tabletsModafinil suppliers USAModafinil for narcolepsy and sleep apneaWholesale Modafinil priceCertified reference material Modafinil

About Modafinil

2-[(Diphenylmethyl)sulfinyl]acetamide (CAS 68693-11-8) serves as a critical component in the United States API intermediates market, primarily utilized for the synthesis of wakefulness-promoting agents where a Pharma/API purity of 99% is required to meet stringent FDA standards. Benzhydrylsulfinylacetamide demand is cu...

Modafinil Specifications

CAS Number

68693-11-8

Molecular Formula

C15H15NO2S

Molecular Weight

273.35 g/mol

IUPAC Name

2-[(diphenylmethyl)sulfinyl]acetamide

Canonical SMILES

C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)C(=O)N

InChI Key

YFGHCGITMMYXAQ-UHFFFAOYSA-N

InChI

InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)

PubChem CID

4236

EINECS Number

640-968-7

MDL Number

MFCD00868082

HSN No

29309090

CAS Number

68693-11-8

Molecular Formula

C15H15NO2S

Molecular Weight

273.35 g/mol

IUPAC Name

2-[(diphenylmethyl)sulfinyl]acetamide

Canonical SMILES

C1=CC=C(C=C1)C(C2=CC=CC=C2)S(=O)C(=O)N

InChI Key

YFGHCGITMMYXAQ-UHFFFAOYSA-N

InChI

InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)

PubChem CID

4236

EINECS Number

640-968-7

MDL Number

MFCD00868082

HSN No

29309090

Molecular Weight

273.35 g/mol

Boiling Point

559.1±50.0 °C (Predicted)

Density

1.283±0.06 g/cm3

PSA

66.15 Å²

Average mass

273.35 g/mol

Monoisotopic mass

273.08234989 Da

Molar mass

273.35 g/mol

Vapour pressure

0 Pa at 25 °C

Precautionary Statement Codes

P201, P202, P260, P264, P270, P271, P280, P301+P312, P330, P304+P340, P308+P313, P314, P405, and P501

Hazard Classes and Categories

Repr. 2 (100%) STOT RE 2 (100%)

Wakefulness-Promoting Agent

A central nervous system stimulant indicated to improve wakefulness in adult patients with excessive sleepiness associated with narcolepsy, obstructive sleep apnea, or shift work disorder

Cognitive Enhancer

A pharmaceutical nootropic agent used off-label to enhance executive functions such as planning, decision-making, and fluid intelligence in healthy individuals

Therapeutic Adjunct

A secondary treatment used alongside continuous positive airway pressure (CPAP) machines to manage residual daytime sleepiness in patients with obstructive sleep apnea

Fatigue Management Agent

A clinical intervention used off-label to mitigate debilitating fatigue associated with medical conditions such as multiple sclerosis, major depressive disorder, and certain cancers.